SCREEN-ERR® is a service designed to help companies evaluate multiple pharmaceutical trademark candidates at an early phase of trademark development. Once preliminary legal screening has taken place, SCREEN-ERR® can determine whether any regulatory or other concerns exist which may result in a name deemed unacceptable to regulatory health authorities. It can be performed using global information resources, but SCREEN-ERR® can be tailored to specific jurisdictions of interest.

SCREEN-ERR® looks for obvious and potential regulatory conflicts. It is not intended to replace or supersede the ERRS MODEL® safety testing, which incorporates a different range of criteria such as handwritten and verbal confusability of trademarks. It does consider each trademark candidate, providing a “green-yellow-red” rating of acceptability.

For our clients, SCREEN-ERR® offers an efficient way to identify unacceptable candidates, saving both time and money.